Company Data
INmune Bio Inc.
Ticker
INMB
Current Price
$1.9 -8.21%
Market Cap
$50.5M
Price Target
Refer to Report
Volume
788.6K
52wk Range
$1.09 - $3.244
Overview
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient’s innate immune system to allow the immune system to fight cancer. The company’s pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.